Steven

68 posts

Steven

Steven

@sorryindy

Katılım Nisan 2026
17 Takip Edilen4 Takipçiler
Steven
Steven@sorryindy·
@TeamDogo @Dr_Jamaloodeen Agreed there’s no way they keep releasing these daily if we weren’t close and I don’t mean months or weeks
English
1
0
4
49
N
N@TeamDogo·
@Dr_Jamaloodeen $TXTM Listen up people…Doc has beating the war drums on this message, over and over and over and DAILY!!…MULTIPLE TIMES DAILY!!…aint for nothing he's doing it…THINK!!…I think it's because UR time is CLOSE!!!⏰
English
1
0
4
214
Dr J
Dr J@Dr_Jamaloodeen·
Dr J tweet media
ZXX
1
2
29
391
Jason Grasse
Jason Grasse@grasse_jason·
@sorryindy YOu sound like the boy who cried wolf.... 8 B OS.. why would it take off?
English
1
0
0
68
Steven
Steven@sorryindy·
Maybe it’s just me, but with all these posts as of late, I think this is happening any say now $Txtm #Txtm
Protext Pharma@ProtextP

🔥ProText Mobility Inc. $TXTM 🔥 MOST PEOPLE WON’T BE EARLY. NOT BECAUSE THEY MISSED IT… BUT BECAUSE THEY DIDN’T RECOGNISE IT.** This is Where Things Start to Separate. Because Right Now, $TXTM is Still Being Viewed by Many as: – Another Ticker – Another Project – Another “Wait and See” Situation And that’s Exactly Why the Opportunity Exists. Because the Market Always Does this. It Underestimates: 👉 Infrastructure 👉 Early-Stage Execution 👉 Systems that Aren’t “Loud” Yet Until Suddenly… It’s No Longer Early. By the time the Majority Recognises what’s Being Built: ✔️ Validation is Already Complete ✔️ Ecosystems are Already Forming ✔️ Partnerships are Already Developing And most importantly: The Asymmetric Upside is Already Gone. This is the Phase Where: – Information is Available – Proof is Emerging – But Attention is Still Low That’s the Window. And it doesn’t Stay Open for Long. Because Once the Shift Happens, the Narrative Changes Fast: From: “Is this Real?” To: “Why wasn’t I Paying Attention?” And then: “Is it too Late?” That’s How Markets Move. Not Gradually. Suddenly. So the Real Question isn’t: “Is this Worth Watching?” It’s: “Am I Early… or Am I Already Late?” Because in Infrastructure Plays… You don’t get Rewarded for Reacting. You get Rewarded for Recognising Early. POSITIONING IS EVERYTHING. #TXTM #Early #Blockchain #Opportunity #Positioning

English
2
0
10
880
Dr J
Dr J@Dr_Jamaloodeen·
$TXTM #TXTM Web Push … Join The Movement !!! It ain’t if …
Dr J tweet media
English
3
7
29
1.1K
Steven
Steven@sorryindy·
@grasse_jason @ericweinstein01 Nobody knows the answer to that but yet you ask the same question week after week month after month. How are we supposed to know when the cash is coming in? As of January 1, there are 30 employees on the books so I’m assuming there has to be some cash flow
English
0
0
0
24
Eric Weinstein
Eric Weinstein@ericweinstein01·
$TXTM The craziest part is > they are thinking planning and executing simultaneously so far beyond what really anyone can grasp. I can't grasp it but I know 1 thing > generational wealth is staring you in the eyes. This is the future and we're in it and WE will prosper. It's wild
English
1
0
14
533
Steven
Steven@sorryindy·
@Buddlight84 @Dr_Jamaloodeen I’ve said it 1 million times and I will say it 1 million more ……it’s going to be a great summer
English
1
0
3
35
Mike
Mike@Buddlight84·
Most companies overpromise and underdeliver 🚨 Protext Mobility Inc. is doing the opposite. Quietly building ⚙️ • Zero debt 💰 • No dilution mindset 📉 • Institutional partnerships 🤝 • Real-world asset tokenization 🌍 The disconnect won’t last 👀 #TXTM #RWA #Growth
Protext Pharma@ProtextP

Protext Mobility Inc. $TXTM 1/ The Market Doesn’t Reflect What We’re Building. Here’s the reality 👇 2/ We are Executing a Clear Strategy: • Major Exchange Uplisting • Real-World Asset Tokenization • Global Expansion 3/ Our Mission is Simple: Unlock Transformative Shareholder Value & Redefine our Market Position 4/ Built on strong foundations: Sustainable growth + long-term confidence 5/ Insider alignment is unmatched: • Zero selling • Ongoing accumulation 6/ Financial discipline: • Zero debt • Zero reverse splits • No executive salaries 7/ We’ve built institutional-grade liquidity: Positioning for global capital inflows 8/ Strategic partnerships include: BNY Mellon Standard Bank Absa Melville Douglas 9/ Our model bridges two sectors: Biotech + Digital Finance 10/ Biotech foundation: Highly bio-available plant-based formulations pharmaceutical-grade API development 11/ Digital layer: Real-world assets → Tokenized Globally scalable financial products 12/ This unlocks: • Capital flexibility • New revenue channels • DeFi + traditional finance access 13/ Proprietary edge: KettleTech nanotechnology 14/ Result: • Higher bioavailability • Faster absorption • Superior efficacy 15/ We create premium physical assets → then digitize them 16/ Our RWA platform delivers: • Liquidity • Scalability • Borderless commercialization 17/ Growth engine: Fuel reinvestment loop Designed for capital efficiency 18/ Strong balance sheet focus: Every dollar drives intrinsic value 19/ Major catalyst: Transition to IFRS reporting 20/ Unlocking: • Hidden balance sheet value • Global credibility • True price discovery 21/ Institutional readiness: Audited financials incoming 22/ Clear roadmap: Clean capital structure IFRS compliance Independent valuation Exchange uplisting 23/ Macro advantage: USD/ZAR forex tailwinds 24/ Impact: • Increased global revenue • Stronger margins 25/ ESG built in: • Zero waste • Carbon credit integration • Global wellness focus 26/ Governance matters: • Transparency • Zero dilution mindset • Audit standards 27/ We’re improving communication: • Real-time investor access • Enhanced reporting 28/ Focus: Long-term shareholder trust 29/ The reality: We are a fully built growth engine 30/ The opportunity: Closing the gap between market price and intrinsic value 31/ Driven by: • Financial purity • Institutional infrastructure • Breakthrough technology 32/ Final catalysts ahead: • IFRS audits • Formal valuation • Market recognition 33/ We are not starting. We are executing. 34/ The disconnect won’t last. #TXTM #RWA #Biotech #Growth

English
2
3
20
410
Protext Pharma
Protext Pharma@ProtextP·
Protext Mobility Inc. $TXTM 1/ The Market Doesn’t Reflect What We’re Building. Here’s the reality 👇 2/ We are Executing a Clear Strategy: • Major Exchange Uplisting • Real-World Asset Tokenization • Global Expansion 3/ Our Mission is Simple: Unlock Transformative Shareholder Value & Redefine our Market Position 4/ Built on strong foundations: Sustainable growth + long-term confidence 5/ Insider alignment is unmatched: • Zero selling • Ongoing accumulation 6/ Financial discipline: • Zero debt • Zero reverse splits • No executive salaries 7/ We’ve built institutional-grade liquidity: Positioning for global capital inflows 8/ Strategic partnerships include: BNY Mellon Standard Bank Absa Melville Douglas 9/ Our model bridges two sectors: Biotech + Digital Finance 10/ Biotech foundation: Highly bio-available plant-based formulations pharmaceutical-grade API development 11/ Digital layer: Real-world assets → Tokenized Globally scalable financial products 12/ This unlocks: • Capital flexibility • New revenue channels • DeFi + traditional finance access 13/ Proprietary edge: KettleTech nanotechnology 14/ Result: • Higher bioavailability • Faster absorption • Superior efficacy 15/ We create premium physical assets → then digitize them 16/ Our RWA platform delivers: • Liquidity • Scalability • Borderless commercialization 17/ Growth engine: Fuel reinvestment loop Designed for capital efficiency 18/ Strong balance sheet focus: Every dollar drives intrinsic value 19/ Major catalyst: Transition to IFRS reporting 20/ Unlocking: • Hidden balance sheet value • Global credibility • True price discovery 21/ Institutional readiness: Audited financials incoming 22/ Clear roadmap: Clean capital structure IFRS compliance Independent valuation Exchange uplisting 23/ Macro advantage: USD/ZAR forex tailwinds 24/ Impact: • Increased global revenue • Stronger margins 25/ ESG built in: • Zero waste • Carbon credit integration • Global wellness focus 26/ Governance matters: • Transparency • Zero dilution mindset • Audit standards 27/ We’re improving communication: • Real-time investor access • Enhanced reporting 28/ Focus: Long-term shareholder trust 29/ The reality: We are a fully built growth engine 30/ The opportunity: Closing the gap between market price and intrinsic value 31/ Driven by: • Financial purity • Institutional infrastructure • Breakthrough technology 32/ Final catalysts ahead: • IFRS audits • Formal valuation • Market recognition 33/ We are not starting. We are executing. 34/ The disconnect won’t last. #TXTM #RWA #Biotech #Growth
Protext Pharma tweet media
English
13
26
73
6.8K
Steven
Steven@sorryindy·
It is going to be a great summer! $Txtm #Txtm
Protext Pharma@ProtextP

Protext Mobility Inc. $TXTM 1/ The Market Doesn’t Reflect What We’re Building. Here’s the reality 👇 2/ We are Executing a Clear Strategy: • Major Exchange Uplisting • Real-World Asset Tokenization • Global Expansion 3/ Our Mission is Simple: Unlock Transformative Shareholder Value & Redefine our Market Position 4/ Built on strong foundations: Sustainable growth + long-term confidence 5/ Insider alignment is unmatched: • Zero selling • Ongoing accumulation 6/ Financial discipline: • Zero debt • Zero reverse splits • No executive salaries 7/ We’ve built institutional-grade liquidity: Positioning for global capital inflows 8/ Strategic partnerships include: BNY Mellon Standard Bank Absa Melville Douglas 9/ Our model bridges two sectors: Biotech + Digital Finance 10/ Biotech foundation: Highly bio-available plant-based formulations pharmaceutical-grade API development 11/ Digital layer: Real-world assets → Tokenized Globally scalable financial products 12/ This unlocks: • Capital flexibility • New revenue channels • DeFi + traditional finance access 13/ Proprietary edge: KettleTech nanotechnology 14/ Result: • Higher bioavailability • Faster absorption • Superior efficacy 15/ We create premium physical assets → then digitize them 16/ Our RWA platform delivers: • Liquidity • Scalability • Borderless commercialization 17/ Growth engine: Fuel reinvestment loop Designed for capital efficiency 18/ Strong balance sheet focus: Every dollar drives intrinsic value 19/ Major catalyst: Transition to IFRS reporting 20/ Unlocking: • Hidden balance sheet value • Global credibility • True price discovery 21/ Institutional readiness: Audited financials incoming 22/ Clear roadmap: Clean capital structure IFRS compliance Independent valuation Exchange uplisting 23/ Macro advantage: USD/ZAR forex tailwinds 24/ Impact: • Increased global revenue • Stronger margins 25/ ESG built in: • Zero waste • Carbon credit integration • Global wellness focus 26/ Governance matters: • Transparency • Zero dilution mindset • Audit standards 27/ We’re improving communication: • Real-time investor access • Enhanced reporting 28/ Focus: Long-term shareholder trust 29/ The reality: We are a fully built growth engine 30/ The opportunity: Closing the gap between market price and intrinsic value 31/ Driven by: • Financial purity • Institutional infrastructure • Breakthrough technology 32/ Final catalysts ahead: • IFRS audits • Formal valuation • Market recognition 33/ We are not starting. We are executing. 34/ The disconnect won’t last. #TXTM #RWA #Biotech #Growth

English
1
2
13
557
Scott Meyers
Scott Meyers@SMGator86·
@sorryindy @GuyEnfield31944 @Drewbarulla @ProtextP Most business valuations take 2-6 weeks once docs are received depending on complexity. There’s nothing complex here. The entire company is based on 1 thing, seeds. Can’t possible take that long to value them. It should be out already. Needs to be on Q1 fins or huge red flag!
English
3
0
0
61
Protext Pharma
Protext Pharma@ProtextP·
Protext Mobility Inc. $TXTM We HEAR You. Market Volatility does not Reflect what we are Building. Here’s the Reality: 🔹 REAL + DIGITAL VALUE We are Bridging Biotech and Blockchain — Transforming Premium Plant-Based Pharmaceutical Assets (Highly Bio-Available Formulations + API’s) into Scalable Digital Tokens. 🔹 FINANCIAL DISCIPLINE Zero debt. Zero Reverse Splits. Zero Insider Selling. Leadership Continues to Accumulate — Fully Aligned with Shareholders. 🔹 GLOBAL INFRASTRUCTURE IN PLACE Institutional Partnerships (BNY Mellon, Standard Bank, Absa, Melville Douglas) are Establishing Liquidity, Enabling Foreign Capital Flow, and Preparing for Global Scale. 🔹 PROPRIETARY TECHNOLOGY EDGE Kettle Tech Nanotechnology Delivers Superior extraction, higher Bioavailability, and Premium-Grade Assets — the Foundation of our Tokenization Model. 🔹 POWERFUL GROWTH ENGINE Revenue + Reinvestment Loop Designed for Capital Efficiency, Balance Sheet Strength, and Long-Term Intrinsic Value Growth. 🔹 MAJOR CATALYSTS AHEAD • IFRS Audited Financials (Unlocking Hidden Value) • Independent Valuation (True Price Discovery) • Major Exchange Uplisting (Institutional Access) 🔹 MACRO ADVANTAGE Forex Tailwinds (USD/ZAR) + ESG-Aligned Model Amplify Global Revenue Potential. We are not Starting — We Are Executing. The Disconnect Between Price and Value Won’t Last. #TXTM #ShareholderUpdate #RWA #Biotech #Growth
Protext Pharma tweet media
English
6
25
77
4.4K
Steven
Steven@sorryindy·
@GuyEnfield31944 @Drewbarulla @ProtextP It is coming. It has only been 8 weeks since Deloitte was sent the information requested. The process takes months, not days and weeks. I have no clue of a timeframe, but I think it’s going to be a fantastic summer for TXTM shareholders.
English
4
0
1
186
Steven
Steven@sorryindy·
April showers brings May Flowers. Deloitte on the horizon. Going to be a great spring and summer for TXTM shareholders.
Protext Pharma@ProtextP

Protext Mobility Inc. $TXTM We HEAR You. Market Volatility does not Reflect what we are Building. Here’s the Reality: 🔹 REAL + DIGITAL VALUE We are Bridging Biotech and Blockchain — Transforming Premium Plant-Based Pharmaceutical Assets (Highly Bio-Available Formulations + API’s) into Scalable Digital Tokens. 🔹 FINANCIAL DISCIPLINE Zero debt. Zero Reverse Splits. Zero Insider Selling. Leadership Continues to Accumulate — Fully Aligned with Shareholders. 🔹 GLOBAL INFRASTRUCTURE IN PLACE Institutional Partnerships (BNY Mellon, Standard Bank, Absa, Melville Douglas) are Establishing Liquidity, Enabling Foreign Capital Flow, and Preparing for Global Scale. 🔹 PROPRIETARY TECHNOLOGY EDGE Kettle Tech Nanotechnology Delivers Superior extraction, higher Bioavailability, and Premium-Grade Assets — the Foundation of our Tokenization Model. 🔹 POWERFUL GROWTH ENGINE Revenue + Reinvestment Loop Designed for Capital Efficiency, Balance Sheet Strength, and Long-Term Intrinsic Value Growth. 🔹 MAJOR CATALYSTS AHEAD • IFRS Audited Financials (Unlocking Hidden Value) • Independent Valuation (True Price Discovery) • Major Exchange Uplisting (Institutional Access) 🔹 MACRO ADVANTAGE Forex Tailwinds (USD/ZAR) + ESG-Aligned Model Amplify Global Revenue Potential. We are not Starting — We Are Executing. The Disconnect Between Price and Value Won’t Last. #TXTM #ShareholderUpdate #RWA #Biotech #Growth

English
0
0
0
56